Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Armsby

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The American Journal of Physiology|April 1, 1995
Cation transport in mouse erythrocytes: role of K(+)-Cl- cotransport in regulatory volume decreaseC C Armsby, C Brugnara, S L Alper
Clinical Toxicology (Philadelphia, Pa.)|April 18, 2014
Poisonings requiring admission to the pediatric intensive care unit: A 5-year reviewK M Even, C C Armsby, S T Bateman
Annals of the New York Academy of Sciences|July 12, 1995
Inhibition of red cell Ca(2+)-activated K+ transport by clotrimazole does not take place via imidazoline binding sitesI Coupry, C C Armsby, S Alper, et al.
European Journal of Pharmacology|January 4, 1996
Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sitesI Coupry, C C Armsby, S L Alper, et al.
The American Journal of Physiology|March 1, 1996
Resistance to osmotic lysis in BXD-31 mouse erythrocytes: association with upregulated K-Cl cotransportC C Armsby, A K Stuart-Tilley, S L Alper, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activityC Brugnara, C C Armsby, M Sakamoto, et al.
Clinical Chemistry|March 1, 1995
HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agentN Rifai, M Sakamoto, T Law, et al.
The Journal of Membrane Biology|September 1, 1995
Ca(2+)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxinsC Brugnara, C C Armsby, L De Franceschi, et al.
The Journal of Clinical Investigation|March 1, 1996
Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell diseaseC Brugnara, B Gee, C C Armsby, et al.
Annals of the New York Academy of Sciences|July 12, 1995
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazoleC Brugnara, L De Franceschi, C C Armsby, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The American Journal of Physiology|April 1, 1995
Cation transport in mouse erythrocytes: role of K(+)-Cl- cotransport in regulatory volume decreaseC C Armsby, C Brugnara, S L Alper
Clinical Toxicology (Philadelphia, Pa.)|April 18, 2014
Poisonings requiring admission to the pediatric intensive care unit: A 5-year reviewK M Even, C C Armsby, S T Bateman
Annals of the New York Academy of Sciences|July 12, 1995
Inhibition of red cell Ca(2+)-activated K+ transport by clotrimazole does not take place via imidazoline binding sitesI Coupry, C C Armsby, S Alper, et al.
European Journal of Pharmacology|January 4, 1996
Clotrimazole and efaroxan inhibit red cell Gardos channel independently of imidazoline I1 and I2 binding sitesI Coupry, C C Armsby, S L Alper, et al.
The American Journal of Physiology|March 1, 1996
Resistance to osmotic lysis in BXD-31 mouse erythrocytes: association with upregulated K-Cl cotransportC C Armsby, A K Stuart-Tilley, S L Alper, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activityC Brugnara, C C Armsby, M Sakamoto, et al.
Clinical Chemistry|March 1, 1995
HPLC measurement, blood distribution, and pharmacokinetics of oral clotrimazole, potentially useful antisickling agentN Rifai, M Sakamoto, T Law, et al.
The Journal of Membrane Biology|September 1, 1995
Ca(2+)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxinsC Brugnara, C C Armsby, L De Franceschi, et al.
The Journal of Clinical Investigation|March 1, 1996
Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell diseaseC Brugnara, B Gee, C C Armsby, et al.
Annals of the New York Academy of Sciences|July 12, 1995
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazoleC Brugnara, L De Franceschi, C C Armsby, et al.
Pageof 1